Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Epitalon vs MOTS-c
An educational, source-based comparison of Epitalon and MOTS-c — how each peptide works, what it's researched for, and what to know before going deeper.
A synthetic tetrapeptide (Ala-Glu-Asp-Gly) modeled on epithalamin, a pineal gland extract. Research from Russian gerontology groups has examined effects on telomerase activity, melatonin rhythm, and lifespan in rodent and limited human cohorts.
- Telomerase activity (in vitro)
- Circadian and melatonin rhythm
- Age-related morbidity in long-term Russian cohort studies
- • Most research is Russian and methodologically heterogeneous.
- • Not FDA-approved.
- • Independent replication is limited.
A 16-amino-acid peptide encoded within the mitochondrial 12S rRNA gene. Research suggests it activates AMPK, enhances insulin sensitivity, and regulates nuclear gene expression in response to metabolic stress — positioning it as a candidate mitochondrial-nuclear signaling peptide.
- Insulin sensitivity
- Exercise capacity and mitochondrial biogenesis
- Age-related metabolic decline
- Obesity models
- • Early-stage research; no approved human therapeutic use.
- • Long-term effects unknown.
Epitalon vs MOTS-c — Key differences
- Class: Epitalon is classified as Longevity · Circadian, while MOTS-c is Mitochondrial · Metabolic.
- Primary research focus: Epitalon — telomerase activity (in vitro); MOTS-c — insulin sensitivity.
- Tag: Longevity vs Longevity.